Fenel M. Eloi has served on the 908 Devices board since February 2021. He was most recently CFO and then COO of Cell Signaling Technology and previously COO and CFO of Interleukin Genetics and CFO of LifeCell Corp and Genome Therapeutics. He serves on the boards of Standard BioTools and several private life-science companies and is a Managing Partner at P&M Capital Partners. He holds an MBA from Anna Maria College and a B.A. in Business and Finance from Lee University.